Sage Journals: Discover world-class research

Abstract

Objective:

Barriers to medication adherence are common in pediatric epilepsy and associated with nonadherence, suboptimal seizure outcomes, and quality of life. A manualized, family-tailored education and problem-solving adherence intervention to address adherence barriers was tested in a randomized controlled trial in young children (2–12 years) with epilepsy. Study aims were to identify the adherence barriers and solutions chosen by families during intervention.

Method:

Participants with demonstrated suboptimal adherence were randomized to either education attention control or treatment. In this exploratory, secondary analysis, treatment group data were examined, including adherence barriers and solutions discussed during face-to-face problem-solving sessions and telephone follow-ups. Treatment data were independently coded utilizing codebook thematic analysis.

Results:

Twenty-seven children were randomized to treatment (M = 7.5 ± 2.9; 59.1% female). Across sessions, coding revealed 10 adherence barriers: Overall Forgetting (38–57%), Change of Routine (14–24%), Competing Activities (5–19%), Opposition (0–9%), Transition of Responsibility (0–5%), Running Out of Medication (0–10%), Forgetting During Travel (0–10%), Medication Not a Priority (0–5%), Medication Taste (0–5%), and Pill Swallowing (0–5%). Eight solution types were chosen and implemented by families: Environmental Cuing (29–50%), Multi-Pronged solutions (0–24%), Positive Reinforcement (14–23%), Backup Doses (0–14%), Refill Tracking (0–10%), Caregiver Modeling of Adherence Behavior (0–5%), Pill Swallowing Intervention (0–5%), and Other (0–5%). A ninth solution type, Caregiver Reminders, was often incorporated into Multi-Pronged solutions.

Conclusions:

Results highlight key adherence barriers identified by families of children with epilepsy and solutions implemented to address them. These data provide guidance to health care teams on how to successfully address adherence barriers in clinical settings.

Implications for Impact Statement

This study reduces gaps between research and practice by highlighting family-identified medication adherence barriers and solutions successfully implemented over time by families of young children with epilepsy.

Get full access to this article

View all access options for this article.

References

Braun

, & Clarke

(2021a). One size fits all? What counts as quality practice in (reflexive) thematic analysis? Qualitative Research in Psychology, 18(3), 1–25. 10.1080/14780887.2020.1769238

Braun

, & Clarke

(2021b). Can I use TA? Should I use TA? Should I not use TA? Comparing reflexive thematic analysis and other pattern-based qualitative analytic approaches. Counselling & Psychotherapy Research, 21(1), 37–47. 10.1002/capr.12360

Epilepsy Learning Health System . (2021). Medication tools. https://www.epilepsy.com/living-epilepsy/toolbox/medication-tools

Faught

Duh

M. S.

Weiner

J. R.

Guérin

, & Cunnington

M. C.

(2008). Nonadherence to antiepileptic drugs and increased mortality: Findings from the RANSOM Study. Neurology, 71(20), 1572–1578. 10.1212/01.wnl.0000319693.10338.b9

Faught

R. E.

Weiner

J. R.

Guérin

Cunnington

M. C.

, & Duh

M. S.

(2009). Impact of nonadherence to antiepileptic drugs on health care utilization and costs: Findings from the RANSOM study. Epilepsia, 50(3), 501–509. 10.1111/j.1528-1167.2008.01794.x

Graves

M. M.

Roberts

M. C.

Rapoff

, & Boyer

(2010). The efficacy of adherence interventions for chronically ill children: A meta-analytic review. Journal of Pediatric Psychology, 35(4), 368–382. 10.1093/jpepsy/jsp072

Guilfoyle

S. M.

Follansbee-Junger

, & Modi

A. C.

(2013). Development and preliminary implementation of a psychosocial service into standard medical care for pediatric epilepsy. Clinical Practice in Pediatric Psychology, 1(3), 276–288. 10.1037/cpp0000031

Gutierrez-Colina

A. M.

Smith

A. W.

Mara

C. A.

, & Modi

A. C.

(2018). Adherence barriers in pediatric epilepsy: From toddlers to young adults. Epilepsy & Behavior, 80, 229–234. 10.1016/j.yebeh.2018.01.031

Hommel

K. A.

, & Baldassano

R. N.

(2010). Brief report: Barriers to treatment adherence in pediatric inflammatory bowel disease. Journal of Pediatric Psychology, 35(9), 1005–1010. 10.1093/jpepsy/jsp126

10.

Hommel

K. A.

Ramsey

R. R.

Rich

K. L.

, & Ryan

J. L.

(2017). Adherence to pediatric treatment regimens. In Roberts

M. C.

& Steele

R. G.

(Eds.), Handbook of Pediatric Psychology (5th ed., pp. 119–133). Guilford Press.

11.

Kahana

Drotar

, & Frazier

(2008). Meta-analysis of psychological interventions to promote adherence to treatment in pediatric chronic health conditions. Journal of Pediatric Psychology, 33(6), 590–611. 10.1093/jpepsy/jsm128

12.

Loiselle

Rausch

J. R.

, & Modi

A. C.

(2015). Behavioral predictors of medication adherence trajectories among youth with newly diagnosed epilepsy. Epilepsy & Behavior, 50, 103–107. 10.1016/j.yebeh.2015.06.040

13.

Miller

V. A.

, & Jawad

A. F.

(2019). Decision-Making Involvement and Prediction of Adherence in Youth With Type 1 Diabetes: A Cohort Sequential Study. Journal of Pediatric Psychology, 44(1), 61–71. 10.1093/jpepsy/jsy032

14.

Modi

A. C.

Glauser

T. A.

, & Guilfoyle

S. M.

(2020). Supporting Treatment Adherence Regimens in young children with epilepsy and their families: Trial design and baseline characteristics. Contemporary Clinical Trials, 90, 105959. 10.1016/j.cct.2020.105959

15.

Modi

A. C.

Guilfoyle

S. M.

Glauser

T. A.

, & Mara

C. A.

(2021). Supporting treatment adherence regimens in children with epilepsy: A randomized clinical trial. Epilepsia, 62(7), 1643–1655. 10.1111/epi.16921

16.

Modi

A. C.

Rausch

J. R.

, & Glauser

T. A.

(2014). Early pediatric antiepileptic drug nonadherence is related to lower long-term seizure freedom. Neurology, 82(8), 671–673. 10.1212/WNL.0000000000000147

17.

Modi

A. C.

Y. P.

Rausch

J. R.

Peugh

J. L.

, & Glauser

T. A.

(2014). Antiepileptic drug nonadherence predicts pediatric epilepsy seizure outcomes. Neurology, 83(22), 2085–2090. 10.1212/WNL.0000000000001023

18.

Modi

A. C.

Rausch

J. R.

, & Glauser

T. A.

(2011). Patterns of nonadherence to antiepileptic drug therapy in children with newly diagnosed epilepsy. Journal of the American Medical Association, 305(16), 1669–1676. 10.1001/jama.2011.506

19.

Ramsey

R. R.

Zhang

, & Modi

A. C.

(2018). The stability and influence of barriers to medication adherence on seizure outcomes and adherence in children with epilepsy over 2 years. Journal of Pediatric Psychology, 43(2), 122–132. 10.1093/jpepsy/jsx090

20.

Robin

A. L.

, & Foster

S. L.

(1989). Negotiating parent-adolescent conflict: a behavioral family systems approach. Guilford Press.

21.

Simons

L. E.

McCormick

M. L.

Mee

L. L.

, & Blount

R. L.

(2009). Parent and patient perspectives on barriers to medication adherence in adolescent transplant recipients. Pediatric Transplantation, 13(3), 338–347. 10.1111/j.1399-3046.2008.00940.x

22.

Terry

Hayfield

Clarke

, & Braun

(2017). Thematic analysis. SAGE publications. 10.4135/9781526405555.n2

23.

Zack

M. M.

, & Kobau

(2017). National and State Estimates of the Numbers of Adults and Children with Active Epilepsy - United States, 2015. Morbidity and Mortality Weekly Report, 66(31), 821–825. 10.15585/mmwr.mm6631a1

Demystifying a Family-Based Epilepsy Adherence Problem-Solving Intervention: Exploring Adherence Barriers and Solutions

Abstract

Objective:

Method:

Results:

Conclusions:

Implications for Impact Statement

Get full access to this article

References